Nanonetworks in biomedical applications

Jose Luis Marzo, Josep Miquel Jornet, Massimiliano Pierobon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

By interconnecting nanomachines and forming nanonetworks, the capacities of single nanomachines are expected to be enhanced, as the ensuing information exchange will allow them to cooperate towards a common goal. Nowadays, systems normally use electromagnetic signals to encode, send and receive information, however, in a novel communication paradigm, molecular transceivers, channel models or protocols use molecules. This article presents the current developments in nanomachines along with their future architecture to better understand nanonetwork scenarios in biomedical applications. Furthermore, to highlight the communication needs between nanomachines, two applications for nanonetworks are also presented: i) a new networking paradigm, called the Internet of NanoThings, that allows nanoscale devices to interconnect with existing communication networks, and ii) Molecular Communication, where the propagation of chemical compounds like drug particles, carry out the information exchange.

Original languageEnglish (US)
Pages (from-to)800-807
Number of pages8
JournalCurrent drug targets
Volume20
Issue number8
DOIs
StatePublished - Jan 1 2019

Fingerprint

Electromagnetic Phenomena
Internet
Equipment and Supplies
Communication
Pharmaceutical Preparations
Chemical compounds
Transceivers
Telecommunication networks
Network protocols
Molecules

Keywords

  • Bionanothings
  • Molecular communication
  • Nanocommunication
  • Nanonetworks
  • Nanothings
  • Targeted drug delivery

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Nanonetworks in biomedical applications. / Marzo, Jose Luis; Jornet, Josep Miquel; Pierobon, Massimiliano.

In: Current drug targets, Vol. 20, No. 8, 01.01.2019, p. 800-807.

Research output: Contribution to journalArticle

Marzo, Jose Luis ; Jornet, Josep Miquel ; Pierobon, Massimiliano. / Nanonetworks in biomedical applications. In: Current drug targets. 2019 ; Vol. 20, No. 8. pp. 800-807.
@article{39302cca878f4815904713833b625e55,
title = "Nanonetworks in biomedical applications",
abstract = "By interconnecting nanomachines and forming nanonetworks, the capacities of single nanomachines are expected to be enhanced, as the ensuing information exchange will allow them to cooperate towards a common goal. Nowadays, systems normally use electromagnetic signals to encode, send and receive information, however, in a novel communication paradigm, molecular transceivers, channel models or protocols use molecules. This article presents the current developments in nanomachines along with their future architecture to better understand nanonetwork scenarios in biomedical applications. Furthermore, to highlight the communication needs between nanomachines, two applications for nanonetworks are also presented: i) a new networking paradigm, called the Internet of NanoThings, that allows nanoscale devices to interconnect with existing communication networks, and ii) Molecular Communication, where the propagation of chemical compounds like drug particles, carry out the information exchange.",
keywords = "Bionanothings, Molecular communication, Nanocommunication, Nanonetworks, Nanothings, Targeted drug delivery",
author = "Marzo, {Jose Luis} and Jornet, {Josep Miquel} and Massimiliano Pierobon",
year = "2019",
month = "1",
day = "1",
doi = "10.2174/1389450120666190115152613",
language = "English (US)",
volume = "20",
pages = "800--807",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Nanonetworks in biomedical applications

AU - Marzo, Jose Luis

AU - Jornet, Josep Miquel

AU - Pierobon, Massimiliano

PY - 2019/1/1

Y1 - 2019/1/1

N2 - By interconnecting nanomachines and forming nanonetworks, the capacities of single nanomachines are expected to be enhanced, as the ensuing information exchange will allow them to cooperate towards a common goal. Nowadays, systems normally use electromagnetic signals to encode, send and receive information, however, in a novel communication paradigm, molecular transceivers, channel models or protocols use molecules. This article presents the current developments in nanomachines along with their future architecture to better understand nanonetwork scenarios in biomedical applications. Furthermore, to highlight the communication needs between nanomachines, two applications for nanonetworks are also presented: i) a new networking paradigm, called the Internet of NanoThings, that allows nanoscale devices to interconnect with existing communication networks, and ii) Molecular Communication, where the propagation of chemical compounds like drug particles, carry out the information exchange.

AB - By interconnecting nanomachines and forming nanonetworks, the capacities of single nanomachines are expected to be enhanced, as the ensuing information exchange will allow them to cooperate towards a common goal. Nowadays, systems normally use electromagnetic signals to encode, send and receive information, however, in a novel communication paradigm, molecular transceivers, channel models or protocols use molecules. This article presents the current developments in nanomachines along with their future architecture to better understand nanonetwork scenarios in biomedical applications. Furthermore, to highlight the communication needs between nanomachines, two applications for nanonetworks are also presented: i) a new networking paradigm, called the Internet of NanoThings, that allows nanoscale devices to interconnect with existing communication networks, and ii) Molecular Communication, where the propagation of chemical compounds like drug particles, carry out the information exchange.

KW - Bionanothings

KW - Molecular communication

KW - Nanocommunication

KW - Nanonetworks

KW - Nanothings

KW - Targeted drug delivery

UR - http://www.scopus.com/inward/record.url?scp=85066824164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066824164&partnerID=8YFLogxK

U2 - 10.2174/1389450120666190115152613

DO - 10.2174/1389450120666190115152613

M3 - Article

C2 - 30648507

AN - SCOPUS:85066824164

VL - 20

SP - 800

EP - 807

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 8

ER -